Episode 203: Manufacturing Drugs for Rare Diseases in North Carolina with Paul Testa of Kyowa Kirin 

This episode, Matthew and Heather chat with Paul Testa, an Executive Vice President of Kyowa Kirin, a pharma group that develops innovative specialty drugs to raise the health and well being of people across the globe. Paul joins us to discuss Kyowa Kirin’s expansion and economic impact in North Carolina. We also dive into treatment trends for rare diseases as well as the current landscape of supply and demand of medicine post-covid. Tune in now!